Business Description
CK Life Sciences International Holdings Inc
NAICS : 541711
ISIN : KYG2176J1058
Description
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.37 | |||||
| Debt-to-Equity | 1.48 | |||||
| Debt-to-EBITDA | 12.9 | |||||
| Interest Coverage | 0.72 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.34 | |||||
| Beneish M-Score | -2.71 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.5 | |||||
| 3-Year EBITDA Growth Rate | 9.9 | |||||
| 3-Year FCF Growth Rate | 12.9 | |||||
| 3-Year Book Growth Rate | -3.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.82 | |||||
| 9-Day RSI | 40.91 | |||||
| 14-Day RSI | 47.21 | |||||
| 6-1 Month Momentum % | 19.28 | |||||
| 12-1 Month Momentum % | -29.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.56 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 119.74 | |||||
| Days Sales Outstanding | 66.77 | |||||
| Days Payable | 54.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -7.2 | |||||
| Shareholder Yield % | 0.08 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.43 | |||||
| Operating Margin % | 4.69 | |||||
| Net Margin % | -0.35 | |||||
| FCF Margin % | 10.73 | |||||
| ROE % | -0.45 | |||||
| ROA % | -0.17 | |||||
| ROIC % | -2.75 | |||||
| ROC (Joel Greenblatt) % | 8.74 | |||||
| ROCE % | 4.35 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 20.89 | |||||
| Price-to-Owner-Earnings | 64.29 | |||||
| PS Ratio | 0.81 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 4.8 | |||||
| Price-to-Free-Cash-Flow | 7.5 | |||||
| Price-to-Operating-Cash-Flow | 7.5 | |||||
| EV-to-EBIT | 26.26 | |||||
| EV-to-EBITDA | 20.88 | |||||
| EV-to-Revenue | 1.79 | |||||
| EV-to-FCF | 16.77 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Earnings Yield (Greenblatt) % | 3.82 | |||||
| FCF Yield % | 13.57 | |||||
| Forward Rate of Return (Yacktman) % | 2.71 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CK Life Sciences International Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 635.68 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | -0.42 | ||
| Volatility % | 57.02 | ||
| 14-Day RSI | 47.21 | ||
| 14-Day ATR (€) | 0.000669 | ||
| 20-Day SMA (€) | 0.048825 | ||
| 12-1 Month Momentum % | -29.79 | ||
| 52-Week Range (€) | 0.0315 - 0.068 | ||
| Shares Outstanding (Mil) | 9,611.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CK Life Sciences International Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CK Life Sciences International Holdings Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
CK Life Sciences International Holdings Inc Frequently Asked Questions
What is CK Life Sciences International Holdings Inc(FRA:LSI)'s stock price today?
The current price of FRA:LSI is €0.05. The 52 week high of FRA:LSI is €0.07 and 52 week low is €0.03.
When is next earnings date of CK Life Sciences International Holdings Inc(FRA:LSI)?
The next earnings date of CK Life Sciences International Holdings Inc(FRA:LSI) is .
Does CK Life Sciences International Holdings Inc(FRA:LSI) pay dividends? If so, how much?
CK Life Sciences International Holdings Inc(FRA:LSI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers